Unique focus on Duodenum – the body’s Metabolic Control Center.
Obesity: A Costly Global Epidemic
Worldwide obesity has nearly tripled since 1975. Most of the world's population lives in countries where obesity and its co-morbidities are a leading cause of death.
36.5%
of adults in the United States are obese
60+
chronic diseases are linked to obesity
$147bn / year
Annual cost of obesity to Americans
300k deaths
Per year are due to obesity in the United States
Source: WHO-2021
The Benefits
Product Evolution
Significant Progress has been made
>17 pre-clinical experiments and clinical trials
involving more than 100 subjects
Top-line benefits include:
EndoSphere’s devices are incisionless, removable and repeatable.
EndoSphere’s devices are NOT RESTRICTIVE DEVICES. They represent a completely new category of endoscopic devices that its founders refer to as “Endo-Metabolic,” “Physiologic-Amplifying”, “Hormonal-Regulating,” and “Satiety-Inducing” devices.
EndoSphere’s devices have been clinically proven to facilitate Excess Weight Loss (EWL) without the need for surgery or weight-loss drugs, and without the need to restrict the available capacity of the patient’s stomach.
